Communiqués

25/03 Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock GL
24/03 Enzon Announces Reverse Stock Split GL
19/03 Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock GL
16/03 Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock GL
11/03 Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock GL
09/03 Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock GL
27/02 Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock GL
30/01 Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger GL
24/10/25 Enzon and Viskase Announce Amendment to Merger Agreement GL
21/06/25 Enzon and Viskase Enter into Merger Agreement AQ
21/06/25 Enzon and Viskase Enter into Merger Agreement GL
05/05/23 ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
16/02/23 ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ
06/01/23 ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K) AQ
09/11/22 ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
04/08/22 ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
15/06/22 ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
26/04/22 ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
25/02/22 ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ
05/11/21 ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
05/08/21 ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
08/06/21 Enzon Pharmaceuticals : CONTINENTAL STOCK TRANSFER & TRUST COMPANY (Form 8-K) PU
08/06/21 ENZON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
04/05/21 ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
23/02/21 ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) AQ
Aucun résultat pour cette recherche